Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

EXCELL CLINICAL LABORATORY, INC.

NPI: 1215038310 · CRANFORD, NJ 07016 · Clinical Medical Laboratory · NPI assigned 09/25/2006

$1.96M
Total Medicaid Paid
301,659
Total Claims
210,487
Beneficiaries
107
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBELOTSERKOVSKY, MARINA (PRESIDENT)
NPI Enumeration Date09/25/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 8,550 $115K
2019 14,419 $208K
2020 28,473 $336K
2021 54,778 $508K
2022 81,734 $526K
2023 64,790 $156K
2024 48,915 $112K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 17,897 8,602 $771K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 8,160 5,992 $578K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 23,719 9,564 $205K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 18,928 7,572 $90K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,497 2,364 $53K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 10,089 7,629 $35K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 725 556 $31K
80061 Lipid panel 15,912 13,108 $23K
82607 8,789 6,074 $18K
80053 Comprehensive metabolic panel 17,457 14,480 $14K
84443 Thyroid stimulating hormone (TSH) 11,884 10,116 $13K
80050 General health panel 944 560 $13K
83036 Hemoglobin; glycosylated (A1C) 14,919 11,821 $11K
82746 6,134 4,132 $9K
84153 3,020 2,232 $7K
82728 4,116 3,271 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 656 512 $6K
86141 1,713 944 $6K
84480 3,635 3,042 $5K
84439 4,048 3,454 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 17,600 14,349 $5K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 8,199 2,927 $5K
86376 463 457 $4K
86769 664 535 $3K
84481 872 821 $3K
83550 4,519 3,468 $3K
83735 4,248 3,611 $2K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 10,149 6,115 $2K
81001 9,187 7,839 $2K
84436 4,182 3,055 $2K
83540 4,594 3,655 $2K
82043 4,864 4,178 $2K
86703 406 283 $2K
84479 2,921 2,192 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 331 199 $2K
87086 Culture, bacterial; quantitative colony count, urine 3,113 2,361 $1K
87481 341 291 $1K
82570 4,880 4,195 $1K
84550 2,628 2,306 $1K
36415 Collection of venous blood by venipuncture 17,951 13,497 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 59 53 $821.30
85045 1,215 1,025 $775.74
84403 364 286 $730.83
83880 511 397 $721.92
86803 395 285 $597.80
85651 4,043 3,303 $584.93
80361 150 125 $560.00
80358 148 124 $545.00
80348 148 123 $545.00
80364 145 120 $540.00
80367 139 117 $525.00
80048 Basic metabolic panel (calcium, ionized) 1,071 903 $504.15
86140 2,177 1,548 $472.08
82248 1,138 880 $443.37
86431 673 554 $437.36
84402 287 227 $433.63
86038 591 465 $425.15
86618 45 32 $388.43
87077 693 614 $378.27
86617 14 14 $342.60
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 320 275 $329.20
87653 343 293 $307.70
87088 794 709 $293.01
87641 297 252 $286.27
80350 82 69 $285.00
82550 583 481 $281.99
84207 12 12 $277.52
86706 282 187 $262.05
83785 12 12 $242.96
87186 431 396 $200.85
80074 12 12 $185.29
85610 2,141 1,183 $156.30
84466 216 179 $145.08
84446 12 12 $140.08
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 1,004 596 $137.93
84100 956 754 $135.08
87340 84 63 $124.91
84425 12 12 $120.00
84590 12 12 $114.64
87581 62 53 $109.48
87486 63 53 $109.48
82270 82 62 $93.11
80349 21 18 $90.00
84252 12 12 $90.00
82180 13 13 $82.80
80356 19 18 $75.00
84630 13 13 $63.20
87500 52 45 $56.14
84154 28 26 $54.70
80365 15 14 $50.00
82977 28 25 $35.58
86592 428 371 $31.54
84146 36 19 $27.14
80164 47 26 $10.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 45 37 $6.67
82985 18 14 $6.60
86060 17 12 $3.60
87640 30 26 $0.00
87556 30 26 $0.00
83615 16 15 $0.00
80372 142 119 $0.00
83970 13 13 $0.00
87563 30 26 $0.00
82652 14 14 $0.00
80354 150 124 $0.00
80369 130 112 $0.00
80373 140 118 $0.00